Cardioselective β 1 -blockers (such as metoprolol, bisoprolol and atenolol) have a greater inhibition of β 1 -adenoceptors than
Introduction: Patients with asthma often have important co-morbidities
bisoprolol and metoprolol), the two exceptions being propranolol for migraine in young
1986
asthma, chronic obstructive pulmonary disease ( COPD ), sleep apnea, or
The rate of overall nonfatal serious adverse events was 0
increase in asthma exacerbations with cardio-selective beta 1-blocker treatment
Therapy with metoprolol should be administered cautiously in patients with liver disease
AECOPD
For people with diabetes: Metoprolol may eliminate The Heart Failure Society of America's comprehensive practice guidelines for HF have recommended the use of β-blockers, even in patients with COPD, 1 but concern about the detrimental effect of this therapy on COPD has led to its suboptimal use
In comparison to immediate-release metoprolol, it can be administered once daily
3 Bisoprolol has a long elimination half‐life (about 11 h in the healthy population and 17 h in CHF patients Metoprolol may worsen the symptoms of heart failure in some patients
The Baby asprin is low dose and should be well tolerated unless you have asthma
{{configCtrl2
Metoprolol can aggravate breathing difficulties in patients with asthma, chronic bronchitis, or emphysema
Patients with preexisting heart failure are at greater risk of decompensated heart failure and cardiogenic shock
Metoprolol tartrate, USP is a selective beta 1 -adrenoreceptor blocking agent, available as 25, 50 and 100 mg tablets for oral administration
Check with your doctor right away if you are having chest pain or discomfort, dilated neck veins, extreme fatigue, irregular breathing or heartbeat, swelling of the face, fingers, feet, or lower legs, trouble breathing, or weight gain